looks like almost 20 million shares purchased by insiders in just the last 6 month versus ZERO sold!
I doubt that there is any good news very close.That would open them to insider trading charges.However sometimes inside trading isn,t what it seems,Many people offset their risk with options.That can,t be the case here because we don,t have options on this stock!The buyers must just have faith!Might be a good idea for us too.Be patient.
That is a good question but the Yahoo message board is unlikely to provide a knowledgeable response.
The claim is that hpSC cell lines immune match a large portion of the population and with multiple cell lines they would match a majority of the population. Aside from the immune advantage over hESC I have seen little discussion as to whether the cells work as well as hESCs.
I don't see the company going out of business. But I have to see if it drop's to .06 to bring my average down. I bought to high.
Just wondering does this stock...........EVER have more than a 1 day winning streak?? I know the volume is light but jeez...LOL It seems like its slowly dripping down and down.
Daily average volume just over 200K lately...so barely any volume but who's selling this cheap.
Not sure what the catalyst will be, but I think it won't take much to take it at least around 0.15 in few days.
Again stop selling this cheap.... Go longs.
Sentiment: Strong Buy
I hope so. I hold 100K of this one. Hopfully the move up will start soon,
Insider purchases by VP, CFO and Director of Legal Affairs and Operations reported yesterday. A Lot of insiders buying lately. Good sign?
International Stem Cell Corporation to Present at Two Upcoming Investment Conferences
CARLSBAD, CA--(Marketwired - August 28, 2014) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, today announced that Executive Vice President Dr. Simon Craw will present a corporate overview of ISCO and its subsidiaries at two upcoming investment conferences.
Rodman and Renshaw 16(th) Annual Global Investment Conference:
Date: Wednesday, September 10, 2014
Time: 11:40 a.m. ET
Location: New York Palace Hotel, New York, NY
Room: Kennedy I
Conference details: http://www.meetmax.com//sched/event_23003/public/conference_home.html?event_id=23003
I had to sell awhile back cuz I needed the fun tickets but plan on coming back soon and with many more shares. ISCO has so much potential down the road. I still check the mb frequently and see the price seems to have found a bottom in the mid .10's. Hope for you guys it moves up but hope for me it stays around that price so I can gather more shares. Good luck to all.
Sentiment: Strong Buy
Insider Transactions Reported - Last Two Years
Date Insider Shares Type Transaction Value*
Aug 6, 2014 SEMECHKIN RUSLANOfficer 1,000,000 Direct Purchase at $0.10 per share. 100,000
Aug 6, 2014 SEMECHKIN ANDREYOfficer 5,000,000 Direct Purchase at $0.10 per share. 500,000
Jun 26, 2014 SEMECHKIN ANDREYOfficer 4,800,000 Direct Purchase at $0.10 per share. 480,000
Jun 26, 2014 SEMECHKIN RUSLANOfficer 700,000 Direct Purchase at $0.10 per share. 70,000
Jun 11, 2014 SEMECHKIN ANDREYOfficer 10,504,584 Direct Option Exercise N/A
Jun 11, 2014 SEMECHKIN RUSLANOfficer 1,601,200 Direct Option Exercise N/A
May 29, 2014 SEMECHKIN RUSLANOfficer 463,333 Direct Purchase at $0.15 per share. 69,499
May 29, 2014 SEMECHKIN ANDREYOfficer 2,870,000 Direct Purchase at $0.15 per share. 430,500
May 8, 2014 DON WRIGHTDirector 65,000 Direct Acquisition (Non Open Market) at $0 per share. N/A
May 8, 2014 CASAMENTO CHARLES JDirector 40,000 Direct Acquisition (Non Open Market) at $0 per share. N/A
May 8, 2014 MAIER PAUL VDirector 40,000 Direct Acquisition (Non Open Market) at $0 per share. N/A
Mar 21, 2014 CASAMENTO CHARLES JDirector 162,500 Direct Acquisition (Non Open Market) at $0 per share. N/A
Mar 21, 2014 DON WRIGHTDirector 162,500 Direct Acquisition (Non Open Market) at $0 per share. N/A
Mar 21, 2014 MAIER PAUL VDirector 162,500 Direct Acquisition (Non Open Market) at $0 per share. N/A
Oct 18, 2013 SEMECHKIN ANDREYOfficer 2,754,821 Direct Option Exercise at $0.15 per share. 413,223
Oct 16, 2013 SEMECHKIN RUSLANOfficer 666,667 Direct Option Exercise at $0.15 per share. 100,000
Jul 24, 2013 SEMECHKIN RUSLANOfficer 667,667 Direct Purchase at $0.15 per share. 100,150
Jul 24, 2013 SEMECHKIN ANDREYOfficer 5,998,999 Direct Purchase at $0.15 per share. 899,849
Jun 20, 2013 DON WRIGHTDirector 65,000 Direct Acquisition (Non Open Market) at $0 per share. N/A
Jun 20, 2013 BERGLUND JAMES HDirector 40,000 Direct Acquisition (Non Open Market) at $0 per share. N/A
Jun 20, 2013 MAIER PAUL VDirector 40,000 D
Sentiment: Strong Buy
It may be, so that means absolutely nothing to the stock price cause Johnny's face has no direct correlation to the market as I can tell based on science.
If our skin care products are good enough to be sold by dr,s etc.thye should be good enough to mas market.It would make excellent copy to advertise that it 'up until now only sold through drs office'! Any thimbs down please say why.You might be right!
The real catalyst here could be Rohto's licensing.
At CC they mentioned 12 months max. for Rohto to examine test results and decide.
I still think ISCO is dirt cheap with its current market cap. It should be at $100M market cap at least.